Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |